|[July 30, 2014]
Research and Markets: Allergic Rhino-Conjunctivitis - Pipeline Review, H1 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/zwj5v2/allergic)
has announced the addition of the "Allergic
Rhino-Conjunctivitis - Pipeline Review, H1 2014" report to
This report provides comprehensive information on the therapeutic
development for Allergic Rhino-Conjunctivitis, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Allergic Rhino-Conjunctivitis and special features on late-stage and
Drug profiles/records featured in the report undergoes periodic updation
folowing a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report provides a snapshot of the global therapeutic landscape of
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
The report reviews key players involved in the therapeutics
development for Allergic Rhino-Conjunctivitis and enlists all their
major and minor projects
The report summarizes all the dormant and discontinued pipeline
A review of the Allergic Rhino-Conjunctivitis products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
FAES Farma SA
Allergy Therapeutics plc
Allergopharma Joachim Ganzer KG
Greer Laboratories, Inc.
Circassia Holdings Ltd.
Laboratorios LETI S.L.
Immunomic Therapeutics, Inc.
Bial - Portela & Ca, S.A.
For more information visit http://www.researchandmarkets.com/research/zwj5v2/allergic
[ Back To Technology News's Homepage ]